Tumor samples used to create lab models for drug testing
NCT ID NCT06782451
First seen Jun 27, 2026 · Last updated Jul 21, 2026 · Updated 2 times
Summary
This study takes tumor samples from 50 patients with specific gene mutations to grow tiny 3D cell clusters called spheroids in the lab. These spheroids help researchers test how well new or existing cancer drugs work against tumors with those mutations. The samples are collected during routine biopsies or surgeries, and the study does not provide direct treatment to participants.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NEOPLASM MALIGNANT are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Centre Antoine Lacassagne
RECRUITINGNice, 06189, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new nucleotide analogue boost cancer treatment?
- Could a simple blood test replace invasive tissue biopsies for cancer genetics?
- Experimental drug targets tough blood cancers in first human trial
- New Antibody-Drug conjugate STRO-002 tested in advanced cancers
- Killer virus turned against childhood brain cancer
- Can a short video help cancer patients get better palliative care?